HHLR Fund, L.P. - Net Worth and Insider Trading
HHLR Fund, L.P. Net Worth
The estimated net worth of HHLR Fund, L.P. is at least $952 Million dollars as of 2024-06-22. HHLR Fund, L.P. is the 2101 Beneficial owner of InnoCare Pharma Ltd and owns about 200,475,300 shares of InnoCare Pharma Ltd (HKSE:09969) stock worth over $952 Million. Details can be seen in HHLR Fund, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that HHLR Fund, L.P. has not made any transactions after 2022-09-21 and currently still holds the listed stock(s).
Transaction Summary of HHLR Fund, L.P.
HHLR Fund, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, HHLR Fund, L.P. owns 1 companies in total, including InnoCare Pharma Ltd (HKSE:09969) .
Click here to see the complete history of HHLR Fund, L.P.’s form 4 insider trades.
Insider Ownership Summary of HHLR Fund, L.P.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09969 | InnoCare Pharma Ltd | 2022-09-21 | 2101 Beneficial owner |
HHLR Fund, L.P. Latest Holdings Summary
HHLR Fund, L.P. currently owns a total of 1 stock. HHLR Fund, L.P. owns 200,475,300 shares of InnoCare Pharma Ltd (HKSE:09969) as of September 21, 2022, with a value of $952 Million.
Latest Holdings of HHLR Fund, L.P.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09969 | InnoCare Pharma Ltd | 2022-09-21 | 200,475,300 | 4.75 | 952,257,675 |
Holding Weightings of HHLR Fund, L.P.
HHLR Fund, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, HHLR Fund, L.P. has made a total of 3 transactions in InnoCare Pharma Ltd (HKSE:09969) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in InnoCare Pharma Ltd is the sale of 0 shares on September 21, 2022, which brought HHLR Fund, L.P. around $0.
Insider Trading History of HHLR Fund, L.P.
- 1
HHLR Fund, L.P. Trading Performance
GuruFocus tracks the stock performance after each of HHLR Fund, L.P.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by HHLR Fund, L.P. is -40.69%. GuruFocus also compares HHLR Fund, L.P.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by HHLR Fund, L.P. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how HHLR Fund, L.P.'s insider trading performs compared to the benchmark.
Performance of HHLR Fund, L.P.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.48 | | | | | |
| Relative Return to S&P 500(%) | 8.4 | | | | | |
HHLR Fund, L.P. Ownership Network
HHLR Fund, L.P. Owned Company Details
What does InnoCare Pharma Ltd do?
Who are the key executives at InnoCare Pharma Ltd?
HHLR Fund, L.P. is the 2101 Beneficial owner of InnoCare Pharma Ltd. Other key executives at InnoCare Pharma Ltd include 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. , Cui Jisong , and 2101 Beneficial owner King Bridge Investments Limited .
InnoCare Pharma Ltd (HKSE:09969) Insider Trades Summary
Over the past 18 months, HHLR Fund, L.P. made no insider transaction in InnoCare Pharma Ltd (HKSE:09969). Other recent insider transactions involving InnoCare Pharma Ltd (HKSE:09969) include a net sale of 259,000 shares made by The Goldman Sachs Group, Inc. , a net sale of 6,000,000 shares made by Zhao Renbin , and a net sale of 5,684,000 shares made by Cui Jisong .
In summary, during the past 3 months, insiders sold 625,000 shares of InnoCare Pharma Ltd (HKSE:09969) in total and bought 316,000 shares, with a net sale of 309,000 shares. During the past 18 months, 18,625,000 shares of InnoCare Pharma Ltd (HKSE:09969) were sold and 316,000 shares were bought by its insiders, resulting in a net sale of 18,309,000 shares.
InnoCare Pharma Ltd (HKSE:09969)'s detailed insider trading history can be found in Insider Trading Tracker table.
InnoCare Pharma Ltd Insider Transactions
HHLR Fund, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for HHLR Fund, L.P.. Currently GuruFocus does not have mailing address information for HHLR Fund, L.P..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
